Your browser doesn't support javascript.
loading
Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer.
Liu, Shih-Hua; Chao, K S Clifford; Leu, Yi-Shing; Lee, Jehn-Chuan; Liu, Chung-Ji; Huang, Yu-Chuen; Chang, Yi-Fang; Chen, Hong-Wen; Tsai, Jo-Ting; Chen, Yu-Jen.
Afiliação
  • Liu SH; Department of Radiation Oncology, Mackay Memorial Hospital, Taipei, Taiwan.
  • Chao KS; Department of Radiation Oncology, Columbia University, New York, New York.
  • Leu YS; Department of Otolaryngology, Mackay Memorial Hospital, Taipei, Taiwan.
  • Lee JC; Department of Otolaryngology, Mackay Memorial Hospital, Taipei, Taiwan.
  • Liu CJ; Department of Oral Surgery, Mackay Memorial Hospital, Taipei, Taiwan.
  • Huang YC; Graduate Institute of Chinese Medical Science, China Medical University, Taichung, Taiwan.
  • Chang YF; Department of Medical Oncology, Mackay Memorial Hospital, Taipei, Taiwan.
  • Chen HW; Department of Radiation Oncology, Mackay Memorial Hospital, Taipei, Taiwan.
  • Tsai JT; Department of Radiation Oncology, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan.
  • Chen YJ; Department of Radiation Oncology, Mackay Memorial Hospital, Taipei, Taiwan.
Head Neck ; 37(7): 933-9, 2015 Jul.
Article em En | MEDLINE | ID: mdl-24634078
ABSTRACT

BACKGROUND:

Surgery followed by radiotherapy (RT) is indicated for patients with high-risk oral cavity cancer (OCC). Based on multi-institutional reports, we developed a guideline for postoperative RT for patients with OCC.

METHODS:

A multidisciplinary OCC team was recruited to develop a questionnaire concerning details of risk-factor categorization, target delineation, and dose specification. Thirty-one radiation oncologists from 18 institutions completed the questionnaire, and data were subjected to extensive review to establish the guideline by expert meeting. In this study, we also report the results for patients treated in accordance with the guideline at our institution between 2007 and 2011.

RESULTS:

Forty-one patients received RT compatible with this guideline with a median 26.8-month follow-up. Thirty-two patients (78%) remained disease-free, 6 (15%) developed locoregional recurrence (4 in-field, 1 marginal, and 1 out-field) and 4 (10%) developed distant metastasis. The overall 2-year survival rate was 86.7%.

CONCLUSION:

This guideline is promising and should be validated and refined in further clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Radioterapia de Intensidade Modulada Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Radioterapia de Intensidade Modulada Idioma: En Ano de publicação: 2015 Tipo de documento: Article